Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
| Price | $10.87 |
|---|---|
| Market cap | $267.6M |
| Sector | Financial Services |
| Industry | Shell Companies |
| Exchange | NASDAQ |
| 52-week range | 10.34-10.95 |
| Beta | 0.01 |
Explore TDAC's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.